Schott Pharma AG & CO KGaA (WBO:1SXP) reports a 21% revenue increase and raises its full-year growth guidance, while addressing challenges in production and currency impacts.

Thanks largely to news of a crucial legal settlement, GSK (NYSE: GSK) was one of the better-performing big pharma stocks on ...

during the 6th CII Pharma & Life Sciences Summit 2024 today. He emphasized that the initiative has bolstered domestic ...

As per the Drug Inspector, Food Safety and Drug Administration (FSDA), Gautam Buddh Nagar, Jai Singh, samples of three ...

India’s wealthiest are worth $1.1 trillion, more than twice as rich as a they were in 2019. They added $316 billion or nearly 40% in just the past 12 months. More than 80% of the richest Indians are ...

Mankind Pharma, controlled by billionaire brothers Ramesh and Rajeev Juneja, announced in July plans to buy Mumbai-based ...

The American Hospital Association wants the Biden administration to take immediate actions to increase the supply of IV ...

The biotech sector’s long-term growth is fueled by strong government support, increasing funding and M&A activities, and ...

Norstella LinQ establishes a throughline between the company’s various subsidiaries, utilizing capabilities from Citeline, ...

Amid a transformation effort under CEO Christophe Bourdon, Danish dermatology expert Leo Pharma is embarking on another round ...

We recently compiled a list of the 10 Stocks with Biggest Upside Potential According to Hedge Funds. In this article, we are ...

The agreement frees the British pharma giant from litigating 93% of the state court cases it faced in the U.S.